
Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to existing ones, which allows them to build monopolies, block competition and drive prices up. Health justice lawyer Priti Krishtel sheds light on how we've lost sight of the patent system's original intent -- and offers five reforms for a redesign that would serve the public and save lives. Hosted on Acast. See acast.com/privacy for more information.
اگر پخش یا دانلود این قسمت خراب است، به مدیر اطلاع دهید.
Over a century ago, one part of our DNA got labelled the "sex chromosomes." Science journalist and Radiolab producer Molly Webster explains the consequences of that oversimplification. This is an excerpt from the TED…
Countless poets and writers have tried to put words to the experience of a panic attack— a sensation so overwhelming, many people mistake it for a heart attack, stroke, or other life-threatening crisis. Studies suggest…
What if we could use biology to restore our balance with nature without giving up modern creature comforts? Advocating for a new kind of environmentalism, scientist and entrepreneur Emily Leproust rethinks modern…
Difficult emotions can get under your skin if you're not careful. Sport and performance consultant Jessica Woods calls this the "jumping cholla effect," inspired by a sneaky kind of cactus that detaches and burrows its…
In ancient Greece, the best-known remedy for a long-standing headache was to drill a small hole in the skull to drain supposedly infected blood. Fortunately, doctors today don't resort to power tools to cure headaches,…